Dr. Murad Alahdal, PhD - The First Affiliated Hospital of Shenzhen University  - Postdoctoral Researcher

Dr. Murad Alahdal

PhD

The First Affiliated Hospital of Shenzhen University

Postdoctoral Researcher

Shenzhen , Guangdong | China

Main Specialties: Allergy & Immunology, Clinical & Laboratory Immunology, Molecular Genetic Pathology, Orthopaedic Sports Medicine, Rheumatology

Additional Specialties: Microbiological and Biochemical Pharmacy

ORCID logohttps://orcid.org/0000-0003-1444-6014


Top Author

Dr. Murad Alahdal, PhD - The First Affiliated Hospital of Shenzhen University  - Postdoctoral Researcher

Dr. Murad Alahdal

PhD

Introduction

Currently working at Shenzhen Second People's Hospital (the First Affiliated Hospital of Shenzhen University), Shenzhen, China. Postdoctoral researcher at School of Medicine, Zhejiang University, Hangzhou, China. A doctor of philosophy in Microbiological and Biochemical Pharmacy from School of Life Science and Technology, China Pharmaceutical University, Jiangsu Province, Nanjing City, China. Current scientific career is the molecular immunology and immunotherapy of inflammatory diseases such as osteoarthritis and rheumatoid arthritis. I have good experience in the molecular biology, oncology and immunotherapy of solid tumours such as pancreatic adenocarcinoma, prostate cancer, melanoma, breast cancer ...etc. I have joined some of the diabetes immunotherapy projects and gained good experience during my PhD program. My background and experience in the microbiological studies particularly viruses in the tropical countries is very good.

Primary Affiliation: The First Affiliated Hospital of Shenzhen University - Shenzhen , Guangdong , China

Specialties:

Additional Specialties:

Research Interests:


View Dr. Murad Alahdal’s Resume / CV

Education

Oct 2018
China Pharmceutical Universty
PhD
Microbiological and Biochemical Pharmacy
Jun 2014
Sana'a University
Master
Microbiology
Sep 2015 - May 2014
UKM - Malaysia
Trainging
Virus serotyping
Apr 2014
Los Aalamos National Llaboratory -USA
Experts Meeting
DNA Sequencing
Aug 2013
National center of public health
Trainging
Genotyping
Sep 2010
British institute
High diploma
English study
Jun 2006
Sana'a university
Bachelor
Microbiology

Experience

Oct 2019
International Science and Technology Cooperation Project
Grant
Project No. 1035043
Jan 2019
CAS-PIFI Chinese Academy of Science
Postdoctoral
Project No. 2019PB0032
May 2018
5th China pharmaceutical university international students academic forum of innovation and scientific research
Researcher
winner
Jun 2016
3rd China pharmaceutical university international students academic forum
Researcher
winner
Sep 2015
Yemen cultural exchange grants
PhD
Sep 2015
China scholarship council
PhD
Project No. 2015886042

Publications

23Publications

685Reads

440Profile Views

Ketofol performance to reduce postoperative emergence agitation in children undergoing adenotonsillectomy.

Libyan J Med 2020 Dec;15(1):1688450

Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/19932820.2019.1688450DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882471PMC
December 2020

The role of indoleamine 2,3 dioxygenase 1 in the osteoarthritis.

Am J Transl Res 2020 15;12(6):2322-2343. Epub 2020 Jun 15.

Shenzhen Key Laboratory of Tissue Engineering, Shenzhen Laboratory of Digital Orthopedic Engineering, Shenzhen Second People's Hospital (The First Hospital Affiliated to Shenzhen University, Health Science Center) Shenzhen 518035, P. R. China.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344072PMC
June 2020
3.226 Impact Factor

Molecular functions of FSTL1 in the osteoarthritis.

Int Immunopharmacol 2020 Jun 4;83:106465. Epub 2020 Apr 4.

Department of Orthopedics/Sports Medicine Center, Southwest Hospital, Army Medical University, Chongqing 400038, China; College of Basic Medicine, Army Medical University, Chongqing 400038, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.intimp.2020.106465DOI Listing
June 2020
2.472 Impact Factor

Intra-articular injection of hUC-MSCs expressing miR-140-5p induces cartilage self-repairing in the rat osteoarthritis.

J Bone Miner Metab 2020 May 23;38(3):277-288. Epub 2019 Nov 23.

The First Affiliated Hospital to Shenzhen University, Health Science Center, Shenzhen Second People's Hospital, Shenzhen, 518035, Guangdong Province, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00774-019-01055-3DOI Listing
May 2020
2.460 Impact Factor

Nano-loaded human umbilical cord mesenchymal stem cells as targeted carriers of doxorubicin for breast cancer therapy.

Artif Cells Nanomed Biotechnol 2018 19;46(sup1):642-652. Epub 2018 Feb 19.

a School of Life Science and Technology , China Pharmaceutical University , Nanjing , China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21691401.2018.1434185DOI Listing
August 2019
34 Reads

Overexpression of ClC-3 Chloride Channel in Chondrosarcoma: An In Vivo Immunohistochemical Study with Tissue Microarray.

Med Sci Monit 2019 Jul 8;25:5044-5053. Epub 2019 Jul 8.

Guangdong Provincial Research Center for Artificial Intelligence and Digital Orthopedic Technology, Hand and Foot Surgery Department, Shenzhen Second People's Hospital (The First Hospital Affiliated to Shenzhen University), Shenzhen, Guangdong, China (mainland).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12659/MSM.917382DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637820PMC
July 2019
3 Reads

Inhibition of RM-1 prostate carcinoma and eliciting robust immune responses in the mouse model by using VEGF-M-GnRH-hinge-MVP vaccine.

Genes Immun 2019 03 23;20(3):245-254. Epub 2018 Jan 23.

Department of Biochemistry, Minigene Pharmacy Laboratory, School of Life Science and Technology, China Pharmaceutical University, TongjiaXiang 24, Nanjing, 210009, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41435-017-0005-9DOI Listing
March 2019
15 Reads
2.913 Impact Factor

Novel mutant P277 peptide VP to ameliorate atherogenic side-effects and to preserve anti-diabetic effects in NOD mice.

Exp Cell Res 2018 10 1;371(2):399-408. Epub 2018 Sep 1.

State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Screening, Minigene Pharmacy Laboratory, School of Life Science and Technology, China Pharmaceutical University, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexcr.2018.08.034DOI Listing
October 2018
14 Reads
3.250 Impact Factor

Pharmacological Effects of EGLP-1, a Novel Analog of Glucagon-Like Peptide-1, on Carbohydrate and Lipid Metabolism.

Cell Physiol Biochem 2018 24;48(3):1112-1122. Epub 2018 Jul 24.

State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Screening, School of life Science and Technology, China Pharmaceutical University, Nanjing, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000491978DOI Listing
September 2018
44 Reads
2.880 Impact Factor

Up-regulation of miR-210 induced by a hypoxic microenvironment promotes breast cancer stem cells metastasis, proliferation, and self-renewal by targeting E-cadherin.

FASEB J 2018 Sep 6:fj201801013R. Epub 2018 Sep 6.

State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, Nanjing, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1096/fj.201801013RDOI Listing
September 2018
15 Reads
5.043 Impact Factor

New DiaP277 analogue shifts DCs to tolerogenic, and modulates NF-Kβ1 to suppress autoreactive T lymphocytes in the type 1 diabetic mice.

Autoimmunity 2018 08 1;51(5):210-220. Epub 2018 Nov 1.

c Minigene Pharmacy Laboratory, School of Life Science & Technology , China Pharmaceutical University , Nanjing , PR China.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/08916934.2018.1
Publisher Site
http://dx.doi.org/10.1080/08916934.2018.1519704DOI Listing
August 2018
29 Reads
2.714 Impact Factor

1-Methyl-D-tryptophan Reduces Tumor CD133 cells, Wnt/β-catenin and NF-κβp65 while Enhances Lymphocytes NF-κβ2, STAT3, and STAT4 Pathways in Murine Pancreatic Adenocarcinoma.

Sci Rep 2018 06 29;8(1):9869. Epub 2018 Jun 29.

State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Ability of Biopharmaceuticals, Jiangsu Key Laboratory of Drug Screening, School of life science and Technology, China Pharmaceutical University, Nanjing, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-018-28238-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026162PMC
June 2018
326 Reads
5.080 Impact Factor

α-Ketoglutarate Promotes Pancreatic Progenitor-Like Cell Proliferation.

Int J Mol Sci 2018 Mar 22;19(4). Epub 2018 Mar 22.

State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Screening, School of Life Science and Technology, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms19040943DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979286PMC
March 2018
89 Reads
2.862 Impact Factor

PGLP-1, a novel long-acting dual-function GLP-1 analog, ameliorates streptozotocin-induced hyperglycemia and inhibits body weight loss.

FASEB J 2017 08 1;31(8):3527-3539. Epub 2017 May 1.

State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Screening, School of Life Science and Technology, China Pharmaceutical University, Nanjing, China,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1096/fj.201700002RDOI Listing
August 2017
77 Reads
5.043 Impact Factor

Targeted delivery of doxorubicin by nano-loaded mesenchymal stem cells for lung melanoma metastases therapy.

Sci Rep 2017 03 17;7:44758. Epub 2017 Mar 17.

State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep44758DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355993PMC
March 2017
39 Reads
5.080 Impact Factor

Top co-authors

Liang Jin
Liang Jin

Xijing Hospital

9
Yumeng Shen
Yumeng Shen

WuXi AppTec (Shanghai) Co.

5
Huashan Gao
Huashan Gao

Shanghai Tenth People's Hospital

5
Shanshan Tang
Shanshan Tang

Shanghai Diabetes Institute

5
Yanfeng Zhang
Yanfeng Zhang

Center for Nanochemistry (CNC)

5
Yun Xing
Yun Xing

China Pharmaceutical University

5
Yi Pan
Yi Pan

Nanjing University

4
Zhaocong Yang
Zhaocong Yang

State Key Laboratory of Natural Medicines

4
Daping Wang
Daping Wang

Guangzhou Brain Hospital

4
You Wu
You Wu

Stevens Institute of Technology

3